findmyKOL

Stephen Greene, MD

Enriched profile

Associate Professor of Medicine, Division of Cardiology, and Member of the Duke Clinical Research Institute · Duke Clinical Research Institute

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Durham, NC · Southeast · United StatesSpecialtyAdvanced Heart Failure and Transplant CardiologyFocusHeart Failure Treatment and Management+4
Active KOLLatest publication2026Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Stephen Greene is Associate Professor of Medicine, Division of Cardiology, and Member of the Duke Clinical Research Institute at Duke Clinical Research Institute. OpenAlex indexes 543 publications with 21,352 citations (h-index 65); ClinicalTrials.gov lists 4 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Advanced Heart Failure and Transplant Cardiology profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 14 Oct 2026

Stephen Greene, MD, is Associate Professor of Medicine, Division of Cardiology, and Member of the Duke Clinical Research Institute. The public record shows 543 publications with 21,352 citations (h-index 65), centered on Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors, Diabetes Treatment and Management. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 30 companies.

  • Most recent indexed publication: 2026 · European heart journal
  • Top research focus: Heart Failure Treatment and Management
  • 4 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 30 companies

Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Heart Failure2 trialsType 2 Diabetes1 trialCOVID-191 trialChronic Kidney Disease1 trialRenal Insufficiency, Chronic1 trial

Research focus

OpenAlex concept fingerprint
Heart Failure Treatment and ManagementCardiovascular Function and Risk FactorsDiabetes Treatment and ManagementCardiac pacing and defibrillation studiesPotassium and Related Disorders

Drugs & molecules

across trials, industry payments and publications
Verquvogeneric · VericiguatClinical trials—Industry payments16Publications1Furoscixgeneric · FurosemideClinical trials—Industry payments2Publications3Inpefageneric · SotagliflozinClinical trials—Industry payments18Publications—Wegovygeneric · SemaglutideClinical trials—Industry payments16Publications—Jardiancegeneric · EmpagliflozinClinical trials—Industry payments11Publications—Korlymgeneric · MifepristoneClinical trials—Industry payments9Publications—OsilodrostatClinical trials—Industry payments7Publications—Lokelmageneric · Sodium zirconium cyclosilicateClinical trials—Industry payments6Publications—Veltassageneric · PatiromerClinical trials—Industry payments6Publications—Entrestogeneric · Sacubitril / valsartanClinical trials—Industry payments4Publications—Farxigageneric · DapagliflozinClinical trials—Industry payments4Publications—Mounjarogeneric · TirzepatideClinical trials—Industry payments4Publications—

Works with

trial sponsors and companies reporting payments
Merck Sharp & Dohme LLCClinical trials—Industry payments49Lexicon Pharmaceuticals, Inc.Clinical trials—Industry payments26Novo Nordisk IncClinical trials—Industry payments24AstraZeneca Pharmaceuticals LPClinical trials—Industry payments23Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments15Vifor (International) Ltd.Clinical trials—Industry payments14Novo Nordisk ASClinical trials—Industry payments13Eli Lilly and CompanyClinical trials—Industry payments12E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments11AstraZeneca UK LimitedClinical trials—Industry payments10Roche Diagnostics CorporationClinical trials—Industry payments10Roche Diagnostics International LtdClinical trials—Industry payments10Corcept TherapeuticsClinical trials—Industry payments9Merck Sharp & Dohme CorporationClinical trials—Industry payments7Recordati_Rare_Diseases_Inc.Clinical trials—Industry payments7Lilly USA, LLCClinical trials—Industry payments6Novartis Pharmaceuticals CorporationClinical trials—Industry payments5Otsuka Pharmaceutical Development & Commercialization, Inc.Clinical trials—Industry payments4Duke UniversityClinical trials3Industry payments—Mylan Inc.Clinical trials—Industry payments3Bayer Healthcare Pharmaceuticals Inc.Clinical trials—Industry payments2Idorsia Pharmaceuticals Us IncClinical trials—Industry payments2Sanofi-Aventis U.S. LLCClinical trials—Industry payments2Scpharmaceuticals Inc.Clinical trials—Industry payments2Amgen Inc.Clinical trials—Industry payments1Boehringer Ingelheim International GmbHClinical trials—Industry payments1Boston Scientific CorporationClinical trials—Industry payments1Chugai Pharmaceutical Co., Ltd.Clinical trials—Industry payments1SK Life Science, Inc.Clinical trials1Industry payments—Urovant Sciences IncClinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
543publications

Distinct works indexed by OpenAlex, matched via ORCID; 31 in PubMed.

21,352citations

Total citations across indexed works.

65h-index

Hirsch index (OpenAlex). i10-index 242.

Clinical & industry

trials, payments and federal funding
4clinical trials

Investigator role on registered studies.

View trials ↓
30companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 14 Oct 2026

Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 14 Oct 2026

30 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    67%
    Beta blocker16.1%
    Metoprolol Succinate58%Carvedilol43%
    Part D≥25 patients
    Angiotensin receptor-neprilysin inhibitor (ARNI)14.4%
    Entresto100%
    Part D≥30 patients

    + 6 more classes in this area

  • Metabolism & gastrointestinal

    27.1%
    SGLT2 inhibitor20.4%
    Jardiance90%Farxiga10%
    Part D<11 patients
    GLP-1 receptor agonist5.3%
    Ozempic100%
    Part D<11 patients

    + 1 more class in this area

  • Blood & clotting

    5.9%
    Factor Xa inhibitor4.4%
    Eliquis69%Xarelto31%
    Part D<11 patients
    P2Y12 inhibitor1.5%
    Clopidogrel100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 14 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 14 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Gregg C. Fonarow205Javed Butler172Robert J. Mentz151Muthiah Vaduganathan135Andrew P. Ambrosy84Muhammad Shahzeb Khan84Javed Butler81Adrian F. Hernandez69Marat Fudim69Adam D. DeVore66Clyde W. Yancy54Mihai Gheorghiade51Brooke Alhanti48G. Michael Felker48Christopher M. O’Connor42Faı̈ez Zannad40Pamela N. Peterson35Aldo P. Maggioni34Larry A. Allen33Paul A. Heidenreich31Scott D. Solomon31Karen Chiswell28Haris Subačius28Justin A. Ezekowitz25Mihai Gheorghiade25Jie‐Lena Sun24Harriette G.C. Van Spall24Abdul Mannan Khan Minhas24Marco Metra23Kevin J. Anstrom23Nancy M. Albert23Marvin A. Konstam22Adriaan A. Voors21Eric J. Velazquez20John A. Spertus19Erin D. Michos19Ambarish Pandey19John R. Teerlink18M. Kittleson18Vanessa Blumer18

Online presence

Updated 14 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/stephen-greene-md-a4518b29

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • Apple Podcasts

    podcasts.apple.com/us/podcast/dont-miss-a-beat/id1525969923

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →podcasts.apple.com ↗
  • ResearchGate

    researchgate.net/profile/Stephen-Greene-8

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
  • X / Twitter

    x.com/SJGreene_md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗

Mentions by others

where others cite or feature them
  • Facebook

    facebook.com/heartindiabetes/videos/icymi-dr-stephen-j-greene-assistant-professor-of-cardiology-at-duke-university-s/290872097304833

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗
  • Other

    esc365.escardio.org/person/648062

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →esc365.escardio.org ↗
  • Facebook

    facebook.com/DukeClinicalResearchInstitute/videos/cardiology-fellow-stephen-greene-md-suggests-that-heart-failure-trials-may-benef/399043044180630

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗
  • X / Twitter

    X (Twitter): @SJGreene_md

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 14 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    Northwestern University Feinberg School of Medicine

    2012
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dukehealth.org ↗
  • Board Certified

    American Board of Internal Medicine - Internal Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dukehealth.org ↗
  • Board Certified

    American Board of Internal Medicine - Cardiovascular Disease

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dukehealth.org ↗
  • Board Certified

    American Board of Internal Medicine - Advanced Heart Failure and Transplant Cardiology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dukehealth.org ↗

Editorial & leadership roles

journal and society appointments
  • Writing committee member

    HF STATS 2025: Heart Failure Epidemiology and Outcomes Statistics (Heart Failure Society of America)

    2025
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hfsa.org ↗
  • Co-host

    "Don't Miss a Beat" cardiology research podcast (HCPLive)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dcri.org ↗

Awards & honors

honors on the public record

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.